Mayo Clinic tests vaccine to provide immune response against early breast lesion
Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional ...
Feb 1, 2017
0
0